BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 17 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 18 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 19 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 17 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 18 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 19 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
Market News

Charles Schwab (SCHW) Q4 profit drops 9% misses estimates

Charles Schwab Corporation (NYSE: SCHW) reported a 9% decline in earnings for the fourth quarter of 2019 due to lower revenue. The bottom line missed analysts’ expectations while the top line exceeded consensus estimates. Net income decreased by 9% to $852 million or $0.62 per share. Revenue declined by 2% to $2.61 billion. Analysts had […]

$SCHW January 16, 2020 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$SCHW · Earnings

Charles Schwab Corporation (NYSE: SCHW) reported a 9% decline in earnings for the fourth quarter of 2019 due to lower revenue. The bottom line missed analysts’ expectations while the top line exceeded consensus estimates. Net income decreased by 9% to $852 million or $0.62 per share. Revenue declined by 2% to $2.61 billion. Analysts had […]

· January 16, 2020

Charles Schwab Corporation (NYSE: SCHW) reported a 9% decline in earnings for the fourth quarter of 2019 due to lower revenue. The bottom line missed analysts’ expectations while the top line exceeded consensus estimates.

Net income decreased by 9% to $852 million or $0.62 per share. Revenue declined by 2% to $2.61 billion. Analysts had projected Charles Schwab to post earnings of $0.64 per share on revenue of $2.6 billion for the fourth quarter.

Charles Schwab (SCHW) Q4 2019 Earnings Review

The San Francisco, California-based firm’s net interest revenue declined by 2% in 4Q to $1.6 billion, due to lower interest revenue.

Core net new assets were $66.2 billion in the fourth quarter of 2019. The online brokerage firm attracted 433,000 new brokerage accounts in the quarter, raising the active brokerage accounts to 12.3 million, up 6% year-over-year. Client assets totaled a record $4.04 trillion at quarter-end, up 24% from last year.

Throughout the year, investor sentiment reflected a complex market environment that included ongoing global trade negotiations, the Brexit debate, and an uncertain economic outlook at home. At the same time, stocks continued their steady march upward, with the S&P 500 rising 29% in the year to record levels.

ADVERTISEMENT

Read: Goldman Sachs Q4 earnings review

The Federal Reserve reversed course on monetary policy, cutting the Fed Funds target three times in 2019, and the yield on 10-year Treasury notes hit a low of 1.47% before rebounding to average 2.14% for the year, leaving the rate environment significantly lower than initial expectations.

Overall, the company’s 2019 results emphasize the enduring nature of Schwab’s financial model, which allows it to consistently invest in capabilities and clients while building value for stockholders through the business cycle.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT
ADVERTISEMENT